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Abstract Clonal BHK cells permanently transfected with the 
metabotropic glutamate receptor la  (mGluRla), which is cou- 
pled to phospholipase C, were used to study the phosphorylation 
state of the receptor. Cells were labelled with 32po43-, lysed, the 
receptor immunoprecipitated with specific anti-peptide antibodies 
and the immunoprecipitates analysed by SDS-PAGE followed by 
autoradiography. A significant basal level of receptor phosphoryl- 
ation was observed which was rapidly and transiently increased 
in response to agonist activation of the receptor. This agonist 
effect was found to be dose dependent with a rapid time course 
and could be abolished by the specific PKC inhibitor Ro318220, 
suggesting that PKC was responsible for the agonist mediated 
phosphorylation of the receptor. 
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I. Introduction 
The metabotropic glutamate receptors (mGluRs) constitute 
a distinct family of G-protein linked receptors with seven puta- 
tive membrane spanning domains. They are unusual in that 
they are much larger than, and appear to have little sequence 
homology with any of the other G-protein linked receptors [1]. 
To date seven subtypes of this receptor family have been cloned 
(mGluRl 7), with differing pharmacological properties and 
tissue distributions. These seven receptor subtypes may be fur- 
ther categorized into three subgroups on the basis of sequence 
homology, agonist selectivity and signal transduction pathway. 
One subgroup consists of mGluR1 and mGluR5. The former 
exhibits three splice variants termed mGluR 1 c~, mGluR lfl and 
mGluRlc and the latter two splice variants namely mGluR5a 
and mGluR5b [2-7]. This group of receptors is coupled to 
phospholipase C (PLC) which catalyzes inositol phospholipid 
(IP) hydrolysis, resulting in the production of both diacylglyc- 
erol (DAG) which stimulates protein kinase C (PKC), and 
inositol trisphosphate (IP3) which induces release of calcium 
from intracellular stores [2-6]. Another subgroup consists of 
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mGluR2 and mGluR3, both of which inhibit forskolin stimu- 
lated cAMP formation in transfected chinese hamster ovary 
(CHO) cells [1,8]. The third subgroup is made up of mGluR4, 
mGluR6 and mGluR7, all of which are sensitive to L-AP4 and 
are also coupled to the inhibition of forskolin stimulated cAMP 
formation in transfected CHO cells [8-11]. Recent evidence has 
suggested the existence of a further subtype mGluRS, which is 
highly homologous with mGluR7 [12]. 
Studies carried out in cerebellar granule cells [13] and in rat 
hippocampal s ices [14], have demonstrated that mGluR medi- 
ated IP hydrolysis may be inhibited by direct stimulation of 
PKC using phorbol esters. Co-incubation of phorbol esters 
with PKC inhibitors not only reverses this inhibition but also 
causes a potentiation of the response [14]. Similar results have 
been obtained with the metabotropic glutamate receptor 
mGluRlc~ expressed in permanently transfected baby hamster 
kidney (BHK) cells [15], and this has led to the suggestion that 
agonist induced activation of PKC may result in rapid receptor 
desensitization by a negative feedback mechanism involving a 
PKC mediated phosphorylation event. Further evidence for 
this comes from studies of the mGluR mediated DAG response 
in cerebrocortical nerve terminals [16]. This response was found 
to undergo rapid and reversible desensitization and was 
strongly inhibited by direct stimulation of PKC with phorbol 
ester. Similarly the recovery of the DAG response could be 
prevented by addition of the phosphatase inhibitor okadaic 
acid. 
Studies into the mechanisms of rapid desensitization i  G- 
protein coupled receptors have mainly concentrated on the 
fl2-adrenergic receptor. This has been shown to undergo rapid 
desensitization following agonist stimulation due to phospho- 
rylation of the receptor by the combined actions of protein 
kinase A (PKA) and the fl-adrenergic receptor kinase [17-19]. 
Phosphorylation is believed to result in functional uncoupling 
of the receptor from Gas, causing a decrease in the sensitivity 
of the agonist stimulated cAMP response. Little however is 
known about he mechanisms underlying the rapid desensitiza- 
tion of PLC linked receptors uch as mGluR1 and mGluR5. 
Agonist mediated phosphorylation of both the cqb-adrenergic 
receptor and the m3-muscarinic receptor has been demon- 
strated, and there is evidence to suggest hat this may be in- 
volved in their desensitization, although no direct link between 
these two processes has yet been established [20-23]. Further- 
more, the kinase or kinases responsible for this phosphoryla- 
tion have not been positively identified, although PKC appears 
to have been ruled out following investigations with the specific 
PKC inhibitor Ro318220, in which application of maximal 
doses of this compound failed to inhibit the agonist induced 
phosphorylation of either of these receptors [21,23]. 
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The metabotropic glutamate receptors possess a number of 
C-terminal serine and threonine residues which may provide 
sites for potential regulatory phosphorylation [1]. In view of the 
established importance of PKC in regulating the responses of 
some of these receptors, there appears to be a genuine prospect 
that agonist mediated phosphorylation of PLC linked mGluRs 
could provide a mechanism for rapid, reversible receptor desen- 
sitization. In the following study we demonstrate for the first 
time that a PLC-coupled receptor mGluR 1 c~ expressed in per- 
manently transfected BHK cells is rapidly and transiently 
phosphorylated by PKC in response to agonist, and that the 
time course of phosphorylation is sufficiently rapid for this to 
represent a plausible mechanism for rapid desensitization f the 
receptor. 
2. Materials and methods 
2.1. Materials 
Baby hamster kidney (BHK) cells permanently transfected with the 
metabotropic glutamate receptor mGluRlcc, anti-peptide anti-serum 
A4 to mGluRlc~ together with the corresponding A4 peptide were all 
kindly provided by Dr. E. Mulvihill. This cell line has been extensively 
characterized in the literature with respect to expression of the receptor, 
its agonist selectivity and signal transduction pathway [15,24,25]. The 
antibody A4, raised against an intracellular sequence (EFVYER- 
EGNTEEDEL) from mGluR Ic~ has also been extensively characterised 
[26-28]. Sodium dihydrogen [32p]orthophosphate (1-150 mCi/mg) was 
obtained from Amersham. Methatrexate, S. Aureus insoluble Protein 
A suspension, O-phenanthroline, L-glutamic acid and phorbol 12,13- 
dibutyrate were obtained from Sigma. L-Quisqualic acid and (RS)-4- 
carboxy-3-hydroxyphenylglycine were obtained from Tocris Cookson. 
E-64 and dichloroisocoumarin (DCI) were obtained from Calbiochem. 
Geneticin G-418 sulphate was obtained from Gibco. The specific PKC 
inhibitor Ro318220 [29] was kindly donated by Dr. T.J. Hallam, Roche 
Products Ltd. 
2.2. Tissue culture 
BHK cells stably expressing the T45A clone ofmGluRl~ were grown 
in 25 cm 2 fasks containing 5 ml Dulbecco's Modified Eagle Medium 
(DMEM), 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml pen- 
icillin/streptomycin, 5% foetal calf serum (FCS), 1 pM methatrexate 
and 0.5 mg/ml G-418 sulphate at 37°C and in an atmosphere of 5% 
CO2. 
2.3. Affinity purification of A4 anti-serum 
Crude A4 anti-serum was affinity purified against he A4 peptide 
using the ProtOn Kit (Multiple Peptide Systems, San Diego, CA, USA) 
and using the manufacturers recommended protocol. 
2.4. [J:P]Phosphate labelling of cells, immunoprecipitation and SDS- 
PAGE 
Cell cultures (2 ml) were grown to pre-confluence (70-90%) in 6-well 
plates (Falcon). The cells were washed gently with DMEM (2 ml) 
containing no phosphate, no FCS and no L-glutamine, and then incu- 
bated with 100/ICi/ml [32PO43- ] for 2 h in 1 ml of the same medium at 
37°C and 5% CO2. Agonists and other compounds were added to the 
medium as indicated. The labelling medium was then rapidly removed 
and the cells lysed for 1 min on ice with 1 ml RIPA detergent buffer 
containing 0.5% (v/v) NP40, 0.5% (w/v) sodium deoxycholate, 0.1% 
(w/v) SDS, 1 mM EGTA, 1 mM MgC12, 150 mM NaC1, 1 mM Na3VO4, 
0.05% (w/v) NAN3, 50 mM Tris-HCl (pH 7.4). The lysing medium also 
contained the protease inhibitors o-phenanthroline (20/lg/ml), DCI (22 
pg/ml) and E-64 (18 pg/ml). Cell lysates were centrifuged at14,000 rpm 
at 4°C for 10~l 5 min in an Eppendorf microfuge and the supernatant 
was immunoprecipitated with 1/lg/ml affÉnity purified A4 antibody for 
1 h at 4°C. A 50 ,ul volume of a 1:1 suspension of S. aureus insoluble 
Protein A made up in RIPA buffer was then added to the supernatant 
and samples were rotated at 30 rpm for a further 1 h at 4°C. The Protein 
A IgG-receptor immunocomplex was pelleted at 14,000 rpm then re- 
suspended and washed 3 times in 1 ml RIPA buffer and once in 1 ml 
of 50 mM Tris-HC1, pH 7.4. The pellet was then resuspended in 30 pl 
of sample buffer containing 20 mM DTT, 4% SDS, 20% glycerol and 
100 mM Tris-HCl (pH 6.8), and the immunoprecipitated protein eluted 
by incubation at 70°C for 2 rain. Previous work carried out in this 
laboratory has demonstrated that Tran 35S-labelled mGluRlc~ is quan- 
titatively and specifically immunoprecipitated by the antibody A4 as a 
150 kDa protein [28]. Eluted proteins were resolved by discontinuous 
SDS polyacrylamide gel electrophoresis using 3% polyacrylamide 
stacking els and 7.5% polyacrylamide running els. The gels were dried 
and then exposed to Kodak X-Omat film at -70°C for 15 20 h. Where 
indicated, band intensities were quantified by gray-scale densitometry 
using the software package Optilab (Graftek). 
3. Results 
BHK cells permanently transfected with mGluR l~ were la- 
belled with [32po3-], the cells lysed and the receptor im- 
munoprecipitated with A4 antibody as described in section 2. 
Analysis of the immunoprecipitate by SDS-PAGE followed by 
autoradiography revealed a significant basal level of receptor 
phosphorylation (Fig. 1 a), which was substantially increased in 
response to a 2 min stimulation with either 100/ IM L-quis- 
qualate or 1 mM L-glutamate (Fig. lb). Pre-incubation for 10 
min with the specific PKC inhibitor Ro318220 (10 ~tM) reduced 
receptor phosphorylation below basal levels (Fig. lc), and also 
abolished the agonist induced increase in phosphorylation (Fig. 
I d). Taken together these data suggest that mGluR 1 ~ is rapidly 
phosphorylated by PKC in response to agonist stimulation, and 
that there is a significant basal level of phosphorylation, prob- 
ably resulting from a constitutive activation of PKC in these 
cells. A 10 min incubation with a supra-maximal dose of the 
PKC activator phorbol 12,13-dibutyrate (PdBu) (1/.tM) caused 
a large increase in receptor phosphorylation, confirming that 
mGluR l~ is indeed a substrate for PKC (Fig. le). In a separate 
experiment his phorbol ester induced phosphorylation was 
shown to be completely ablated when 1 /.tM PdBu was co- 
incubated with 10 ¢tM Ro318220 (Fig. 1 ~h). The large quantity 
mGluRl~ 
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Fig. 1. Agonist mediated phosphorylation of mGluRla expressed in 
permanently transfected BHK cells. Cells were grown in identical 2ml 
cultures in a 6-well plate and isotopically labelled with [~2p(y-] for 
2 h as described in section 2. The cells in individual wells were then: 
(a) left untreated as a control; (b) treated with 100 pM L-quisqualate 
for 2 min; (c) treated with 10pM Ro318220 for 10 min; (d) treated with 
10 ,uM Ro318220 for 10 rain followed by 100 ¢tM L-quisqualate for a 
further 2 min (still in the presence of Ro318220); and (e) treated with 
1/.tM PdBu for 10 min. In a separate experiment cells in individual wells 
were (f) left untreated as a control, (g) treated with 1 ¢tM PdBu for 10 
min and (h) co-incubated with 1 pM PdBu and 10 ¢tM Ro318220 for 
10 min. The extracellular medium was then rapidly removed, the cells 
lysed and the receptor immunoprecipitated and analysed by SDS- 
PAGE followed by autoradiography as described in section 2. The 
figure shows data from two separate, representative experiments both 
of which were carried out 3 times. The same results were observed in 
parallel experiments in which cells were stimulated with 1 mM L-gluta- 
mate. 
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Fig. 2. Dose-response curves for agonist mediated phosphorylation f 
mGluRl~ expressed in permanently transfected BHK cells. (A) Cells 
were grown in identical 2 ml cultures in two 6-well plates and isotopi- 
cally labelled with [32p@4 ] for 2 h as described in section 2. The cells 
in individual wells were then either left untreated as a control or treated 
with doses of L-glutamate or L-quisqualate in the range 1, 10, 100 and 
1000 pM for a period of 2 min. The extracellular medium was then 
rapidly removed, the cells lysed and the receptor immunoprecipitated 
and analysed by SDS-PAGE followed by autoradiography as described 
in section 2. (B) The variation in intensity of the 150 kDa band arising 
from application of different doses of agonist was quantified by grays- 
cale densitometry using arbitrary units. The figure shows data from a 
single representative experiment that was carried out 3 times. 
of material at the top of the gel has also been observed in 
immunoprecipitates from Tran 3sS-labelled cell lysates and rep- 
resents aggregated receptor [28]. Although the level of phos- 
phorylation of this material corresponds with that of the 150 
kDa receptor 'monomer', work carried out previously in this 
laboratory has shown that this aggregate cannot be resolved 
fully from underlying non-specifically immunoprecipitated ma- 
terial [28]. Consequently our studies have concentrated on the 
150 kDa form of the receptor which is clearly resolved on SDS 
gels. 
In order to discount he possibility of non-specific effects 
resulting from the use of such high concentrations of agonist, 
the cells were pre-labelled with [32po3-] and then stimulated for 
2 min with concentrations of 1, 10, 100 and 1000 pM of both 
L-glutamate and t-quisqualate. The receptor was analysed by 
SDS-PAGE followed by autoradiography and the variation in 
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intensity of the 150 kDa band was quantified by gray-scale 
densitometry. These studies demonstrated that the degree of 
agonist mediated phosphorylation is not only dependent on the 
agonist concentration (Fig. 2A) but also generated ose re- 
sponse curves for L-glutamate and L-quisqualate that are char- 
acteristic for these agonists acting at mGluR 1 a and which show 
the expected greater efficacy of L-quisqualate as an agonist [15] 
(Fig. 2B). The increase in mGluRl~ phosphorylation associ- 
ated with 100 pM L-glutamate and 5 pM L-quisqualate could 
be reduced but not completely blocked by the selective 
mGluRla  antagonist (RS)-4-carboxy-3-hydroxyphenylglycine 
(data not shown). The failure to block completely these re- 
sponses probably reflects the high concentrations of agonist 
used and the relatively low affinity of this competitive antago- 
nist [30]. Taken together these results show that the agonist 
mediated increase in mGluRhz phosphorylation is due to their 
effects on the receptor and not a consequence of non-specific 
interactions arising from treating the cells with high doses of 
L-glutamate and L-quisqualate. 
The time course of the agonist mediated phosphorylation f 
the receptor was also studied. Cells pre-labelled with [32po3-] 
were stimulated with 100/.tM L-quisqualate or 1 mM L-gluta- 
mate for periods of 1, 2, 5, 15 and 30 rain. The immunoprecip- 
itates were analysed by SDS-PAGE followed by autoradiogra- 
phy, and the variation in intensity of the 150 kDa band was 
quantified by grayscale densitometry (Fig. 3). It was found that 
the level of phosphorylation rose rapidly within the first minute 
following addition of the agonist, peaked at about 2 min and 
then returned back to basal levels approximately 15-30 min 
later. These results demonstrate hat the receptor is rapidly and 
transiently phosphorylated byPKC in response to agonist acti- 
vation, and that this transient phosphorylation displays a rela- 
tively short time course. 
4. Discussion 
The inhibitory effect of PKC activation on the responses of 
certain PLC linked metabotropic glutamate receptors has been 
studied by a number of groups [13-16]. The study by Thomsen 
et al. [15] was carried out using the same BHK cells transfected 
with mGluRhz that we have used in this investigation. In sim- 
ilar experiments we have confirmed both the agonist mediated 
activation of mGluRl~ expressed in these cells and inhibition 
of the receptor mediated responses resulting from pre-activa- 
tion of PKC that Thomsen et al. reported ([15]; Alaluf et al., 
unpublished ata). Together these data suggest that PKC may 
be involved in regulating mGluRla  desensitization i  these 
cells, and the finding in this study that mGluRl~ is rapidly and 
transiently phosphorylated by PKC in response to agonist is 
consistent with this, and represents a potential mechanism by 
which such desensitization may occur. 
The rapid agonist induced increase in receptor phosphoryla- 
tion is consistent with the rapid translocation of PKC to the 
plasma membrane observed in striatal neurons following acti- 
vation of mGluRs [31]. Similarly, the time course of mGluR 1 
phosphorylation observed in this study is remarkably consist- 
ent with the time course of recovery of the desensitized mGluR 
DAG response measured in cerebrocortical nerve terminals by 
Herrero et al. [16]. In that study, no second response to agonist 
was observed until l0 min after the initial response, by which 
time we have shown that the level of receptor phosphorylation 
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Fig. 3. Time course of agonist mediated phosphorylation f mGluRl~ 
expressed in permanently transfected BHK cells. (A) Cells were grown 
in identical 2ml cultures in a 6-well plate and isotopically abelled with 
[3=po~4-] for 2 h as described in section 2. The cells in individual wells 
were then either left untreated as a control or treated with 100/IM 
c-quisqualate for periods of 1, 2, 5, 15 and 30 rain as indicated. The 
extracellular medium was then rapidly removed, the cells lysed and the 
receptor immunoprecipitated an analysed by SDS-PAGE followed by 
autoradiography as described in section 2. The figure shows data from 
a single representative experiment that was carried out 3 times. (B) The 
variation in intensity of the 150 kDa band during the time course was 
quantified by gray-scale densitometry using arbitrary units. A similar 
time course was observed in parallel experiments in which cells were 
stimulated with 1 mM L-glutamate. 
has peaked and is falling. This second response gradually re- 
turned to normal 20 min following the first addition of agonist, 
by which time receptor phosphorylation has almost returned 
to basal evels. It appears therefore that agonist mediated phos- 
phorylation of mGluR 1 ~ does constitute a credible mechanism 
by which the receptor stimulated DAG response may be rapidly 
desensitized. 
The presence of a significant basal level of phosphorylation 
was at first thought o be due to the presence of trace quantities 
of L-glutamate in the [32po3-]- labelling medium. Although L- 
glutamate is rigourously excluded during the [32PO]-]- 
labelling period, it is present in the normal growth medium due 
to the presence of 5% foetal calf serum (FCS). However, we 
have found that pre-incubating the cells with the selective 
mGluR l~ antagonist (RS)-4-carboxy-3-hydroxyphenylglycine 
(1 mM) in FCS-free medium for 24 h before labelling with 
[32po3-]- has no effect on the basal level of receptor phospho- 
rylation (unpublished data). This, together with the fact that the 
PKC inhibitor Ro318220 was able to reduce receptor phospho- 
rylation below basal levels suggests that there is a constitutive 
activation of PKC in these cells. This is not surprising when one 
considers that PKC may be stimulated by many different path- 
ways, not least by the various mitogens and growth factors 
which are always present under normal culture conditions [32]. 
In conclusion, we have observed a rapid, transient phospho- 
rylation of mGluR 1 ~ by PKC in response to agonist activation. 
The degree of phosphorylation is dependent on the agonist 
concentration and we suggest that it may represent a plausible 
mechanism for rapid receptor desensitization. Current investi- 
gations are being directed towards identifying the site or sites 
of phosphorylation i  order to determine more clearly if phos- 
phorylation is indeed responsible for the regulation of receptor 
responses. 
References 
[1] Tanabe, Y., Masu, M., Ishii, T., Shigemoto, R. and Nakanishi, S. 
(1992) Neuron 8, 169-179. 
[2] Masu, M., Tanabe, Y., Tsuchida, K., Shigemoto, R. and 
Nakanisbi, S. (1991) Nature 349, 760-765. 
[3] Houamed, K.M., Kuijper, J.L., Gilbert, T.L., Haldeman, B.A., 
O'Hara, P.J., Mulvihill, E.R., Almers, W. and Hagen, F.S. (1991) 
Science 252, 1318-1321. 
[4] Pin, J.P., Waeber, C., Prezeau, L., Bockaert, J. and Heinemann, 
S.F. (1992) Proc. Natl. Acad. Sci. USA 89, 10331-10335. 
[5] Abe, T., Sugihara, H., Nawa, H., Shigemoto, R., Mizuno, N. and 
Nakanishi, S. (1992) J. Biol. Chem. 267, 13361-13368. 
[6] Minakami, R., Katsuki, F., Yamamoto, T., Nakamura, K. and 
Sugiyama, H. (1994) Biochem. Biophys. Res. Commun. 199, 1136- 
1143. 
[7] Minakami, R., Katsuki, F. and Sugiyama, H. (1993) Biochem. 
Biophys. Res. Commun. 194, 622-627. 
[8] Tanabe, Y., Nomura, A., Masu, M., Shigemoto, R., Mizuno, N. 
and Nakanishi, S. (1993) J. Neurosci. 13, 1372-1378. 
[9] Nakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, 
R., Mizuno, N. and Nakanishi, S. (1993) J. Biol. Chem. 268, 
11868-11873. 
[10] Okamoto, N., Hori, S., Akazawa, C., Hayashi, Y., Sbigemoto, R., 
Mizuno, N. and Nakanishi, S. (1994) J. Biol. Chem. 269, 1231- 
1236. 
[11] Saugstad, J.A., Kinzie, J.M., Mulvihill, E.R., Segerson, T.E and 
Westbrook, G.L. (1994) Mol. Pharmacol. 45, 367-372. 
[12] Duvoisin, R.M., Zhang, C. and Ramonell, K. (1995) J. Neurosci. 
(in press). 
[13] Canonico, EL., Favit, A., Catania, M.V. and Nicoletti, F. (1988) 
J. Neurochem. 51, 104%1053. 
[14] Schoepp, D.D. and Johnson, B.G. (1988) Biochem. Pharmacol. 37, 
42994305. 
[15] Thomsen, C., Mulvihill, E.R., Haldeman, B., Pickering, D.S., 
Hampson, D.R. and Suzdak, P.D. (1993) Brain Res. 619, 22-28. 
[16] Herrero, I., Miras-Portugal, M.T. and S~nchez-Prieto, J. (1994) 
Eur. J. Neurosci. 6, 115-120. 
[17] Bouvier, M., Hausdorff, W.E, De Blasi, A., O'Dowd, B.F., 
Kobilka, B. K., Caron, M.G. and Lefkowitz, R.J. (1988) Nature 
333, 370-373. 
[18] Hausdorff, W.P., Bouvier, M., O'Dowd, B.F., Irons, G.P., Caron, 
M.G. and Lefkowitz, R.J. (1989) J. Biol. Chem. 264, 12657-12665. 
[19] Lohse, M.J., Benovic, J.L., Caron, M.G. and Lefkowitz, R.J. 
(1990) J. Biol. Chem. 265, 3202-3209. 
[20] Leeb-Lundberg, L.M.F., Cotecchia, S., DeBlasi, A., Caron, M.G. 
and Lefkowitz, R.J. (1987) J. Biol. Chem. 262, 3098-3105. 
[21] Lattion A.-L., Diviani, D. and Cotecchia, S. (1994) J. Biol. Chem. 
269, 22887-22893. 
[22] Tobin, A.B., Lambert, D.G. and Nahorski, S.R. (1992) Mol. Phar- 
macol. 42, 1042-1048. 
[23] Tobin, A.B. and Nahorski, S.R. (1993) J. Biol. Chem. 268, 9817- 
9823. 
[24] Pickering, D.S., Thomsen, C., Suzdak, ED., Fletcher, E.J., 
RobitaiUe, R., Salter, M.W., MacDonald, J.F., Huang, X.P. and 
Hampson, D.R. (1993) J. Neurochem. 61, 85-92. 
[25] Thomsen, C., Boel, E. and Suzdak, P.D. (1994) Eur. J. Pharmaeol. 
267, 77-84. 
S. Alaluf et aL /FEBS Letters 367 (1995) 301~05 305 
[26] Hampson, D.R., Theriault, E., Huang, X.E, Kristensen, E, 
Pickering, D. S., Franck, J.E. and Mulvibill, E.R. (1994) Neuro- 
science 60, 325-336. 
[27] Baude, A., Nusser, Z., Roberts, J.D.B., Mulvihill, E., McIlhinney, 
R.A.J. and Sornogyi, E (1993) Neuron 11,771-787. 
[28] Alaluf, S., Mulvihill, E.R. and McIlhinney, R.A.J. (1995) J. Neu- 
rochem. 64, 1548-1555. 
[29] Davis, ED., Hill, C.H., Keech, E., Lawton, G., Nixon, J.S., 
Sedgwick, A.D., Wadsworth, J., Westmacott, D. and Wilkinson, 
S.E. (1989) FEBS Lett. 259, 61-63. 
[30] Thomsen, C. and Suzdak, P.D. (1993) Eur. J. Pharmacol. 245, 
299-301. 
[31] Manzoni, O.J.J., Finiels-Marlier, F., Sassetti, I., Bockaert, J., 
le Peuch, C. and Sladeczek, F.A.J., (1990) Neurosci. Lett. 109, 
146-151. 
[32] Nishizuka, Y. (1992) Science 258, 607 614. 
